Literature DB >> 16466950

Prevalence of -alpha(3.7) and alpha alpha alpha(anti3.7) alleles in sickle cell trait and beta-thalassemia patients in Mexico.

María Paulina Nava1, Bertha Ibarra, María Teresa Magaña, María de la Luz Chávez, F Javier Perea.   

Abstract

The aim of this study was to determine the frequency of alpha-globin gene mutations in three groups of Mexican unrelated individuals. The first two groups were normal and sickle cell trait individuals from the Costa Chica region, a place with a 12.8% frequency of HbS carriers, and the third group comprised of Mexican mestizo patients with beta-thalassemia. We searched for -alpha(3.7) and -alpha(4.2) alpha(+)-thalassemia deletion alleles, as well as the alpha alpha alpha(anti3.7) triplication through long-gap PCR. The alleles -alpha(3.7) and alpha alpha alpha(anti3.7) were found in the heterozygote state only; 19% of the normal subjects had the -alpha(3.7) allele, and 2% showed the alpha alpha alpha(anti3.7) allele. In individuals with the sickle cell trait, 17% had the -alpha(3.7) deletion, and the alpha alpha alpha(anti3.7) triplication was observed in 3% of these individuals. We revealed that 16% of the subjects with beta-thalassemia showed the -alpha(3.7) deletion and 28% the alpha alpha alpha(anti3.7) triplication. The -alpha(4.2) deletion was not detected in any individual. The frequency of the -alpha(3.7) allele was roughly the same in the three groups studied; this can be explained by the fact that the three groups have common genes from Africa and the Mediterranean, where a high prevalence of alpha(+)-thalassemia has been observed. To our knowledge, the frequency of alpha alpha alpha(anti3.7) triplication observed in the Mexican beta-thalassemia patients is the highest reported. As the -alpha(3.7) and alpha alpha alpha(anti3.7) alleles are very common in our selected populations, we believe that there is a need to investigate systematically the alpha-globin gene mutations in all hemoglobinopathies in the Mexican population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16466950     DOI: 10.1016/j.bcmd.2005.12.003

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  5 in total

1.  Alpha-globin gene triplication and its effect in beta-thalassemia carrier, sickle cell trait, and healthy individual.

Authors:  Mohammad Hamid; Bijan Keikhaei; Hamid Galehdari; Alihossein Saberi; Alireza Sedaghat; Gholamreza Shariati; Marziye Mohammadi-Anaei
Journal:  EJHaem       Date:  2021-07-19

2.  Association of Low Serum Iron with Alpha Globin Gene Deletions and High Level of HbF with Xmn-1 Polymorphism in Sickle Cell Traits.

Authors:  S Pandey; R M Mishra; A Suhail; S Rahul; K Ravi; Sw Pandey; T Seth; R Saxena
Journal:  Indian J Clin Biochem       Date:  2011-11-08

3.  β-Globin chain abnormalities with coexisting α-thalassemia mutations.

Authors:  Birol Guvenc; Abdullah Canataroglu; Cagatay Unsal; Sule Menziletoglu Yildiz; Ferda Tekin Turhan; Sevcan Tug Bozdogan; Suleyman Dincer; Hakan Erkman
Journal:  Arch Med Sci       Date:  2012-05-29       Impact factor: 3.318

4.  Genome-wide association study of red blood cell traits in Hispanics/Latinos: The Hispanic Community Health Study/Study of Latinos.

Authors:  Chani J Hodonsky; Deepti Jain; Ursula M Schick; Jean V Morrison; Lisa Brown; Caitlin P McHugh; Claudia Schurmann; Diane D Chen; Yong Mei Liu; Paul L Auer; Cecilia A Laurie; Kent D Taylor; Brian L Browning; Yun Li; George Papanicolaou; Jerome I Rotter; Ryo Kurita; Yukio Nakamura; Sharon R Browning; Ruth J F Loos; Kari E North; Cathy C Laurie; Timothy A Thornton; Nathan Pankratz; Daniel E Bauer; Tamar Sofer; Alex P Reiner
Journal:  PLoS Genet       Date:  2017-04-28       Impact factor: 6.020

5.  Three Mexican Families with β thalassemia intermedia with different molecular basis.

Authors:  Lourdes Del Carmen Rizo de la Torre; Francisco Javier Perea Díaz; Bertha Ibarra Cortés; Víctor Manuel Rentería López; Josefina Yoaly Sánchez López; Francisco Javier Sánchez Anzaldo; María Teresa Magaña Torres; Katia Gonnet; Catherine Badens; Nathalie Bonello-Palot
Journal:  Genet Mol Biol       Date:  2020-02-03       Impact factor: 1.771

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.